Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Autolus Therapeutics PLC
SWB:6A3A
Autolus Therapeutics PLC
SWB:6A3A
Price:
1.78
EUR
Market Cap:
€195.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Autolus Therapeutics PLC
SWB:6A3A
|
UK |
|
Tamburi Investment Partners SpA
MIL:TIP
|
IT |
|
Pangenomic Health Inc
F:LL3
|
CA |
|
Richter Gedeon Vegyeszeti Gyar Nyrt
F:RIG2
|
HU |
|
Softlab SpA
MIL:SFT
|
IT |
Wall St Price Targets
6A3A Price Forecast
Based on 10 analysts
Based on 10 analysts
+375% Upside
from
€1.78
today
Autolus Therapeutics PLC (6A3A)’s 12-month stock price forecast through August 2027 has a consensus target of €8.45, implying 375% upside. The forecast is based on price targets from 10 Wall Street analysts.
6A3A Analyst Rating
No ratings yet
No ratings yet
Autolus Therapeutics PLC Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 6A3A's stock price target?
Price Target
8.45
EUR
8.45
EUR
According to Wall Street analysts, the average 1-year price target for 6A3A is 8.45 EUR with a low forecast of 5.11 EUR and a high forecast of 10.07 EUR.
What is the Revenue forecast for Autolus Therapeutics PLC?
Projected CAGR
40%
40%
Over the last 8 years, the compound annual growth rate for Revenue has been 61%. The projected CAGR for the next 8 years is 40%.